之江生物:公司产品获得国家三类医疗器械注册证
Core Viewpoint - The company has recently obtained a Class III medical device registration certificate for a new product, which is a nucleic acid detection kit for the novel coronavirus 2019-nCoV, indicating a significant advancement in its product offerings and potential market impact [1] Group 1: Product Details - The product is named "Nucleic Acid Detection Kit for Novel Coronavirus 2019-nCoV (Fluorescent PCR Method)" [1] - The registration certificate number is 20253402166, with a validity period from October 27, 2025, to October 26, 2030 [1] - The product utilizes mature fluorescent PCR technology and lyophilization processes, aimed at providing a precise and convenient detection tool for clinical use [1]